Neuroendocrine Hyperplasia of Infancy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Neuroendocrine Hyperplasia of Infancy
Neuroendocrine Hyperplasia of Infancy (NEHI) is a rare lung condition affecting babies, often causing rapid breathing and low oxygen levels. While challenging for families, effective management can significantly improve outcomes. TheDrugClub understands the financial burden of ongoing medical care and helps members save substantially on the essential prescriptions needed for conditions like NEHI, making treatment more accessible.
Neuroendocrine Hyperplasia of Infancy, or NEHI, is a rare pulmonary disorder primarily affecting infants, typically appearing within the first two years of life. It’s characterized by an increased number of specialized cells (neuroendocrine cells) in the small airways of the lungs. This overgrowth can lead to air trapping, inflammation, and difficulty with gas exchange, resulting in symptoms such as tachypnea (rapid breathing), hypoxemia (low oxygen levels), and sometimes wheezing or coughing.
Diagnosis of NEHI often involves a high-resolution computed tomography (HRCT) scan of the chest, which can reveal characteristic ground-glass opacities and air trapping. In some cases, a lung biopsy may be performed to confirm the diagnosis. While NEHI is a chronic condition, many children experience improvement as they grow, often outgrowing the need for significant medical intervention by school age.
Treatment for NEHI is primarily supportive and aims to manage symptoms and ensure adequate oxygenation. Common interventions and medications may include:
- Oxygen Therapy: Many infants with NEHI require supplemental oxygen, especially during sleep, feeding, or illness, to maintain healthy oxygen saturation levels.
- Bronchodilators: Medications like albuterol, often delivered via nebulizer, may be prescribed to help open the airways, although their effectiveness can vary.
- Corticosteroids: While not a primary treatment, inhaled or oral steroids might be used in specific situations to reduce inflammation, though their long-term benefit for NEHI is still being studied.
- Diuretics: In some rare cases, diuretics may be considered if there's evidence of fluid retention affecting lung function.
Managing a condition like NEHI can involve ongoing prescription costs for oxygen supplies, nebulized medications, and other supportive therapies. This is where TheDrugClub steps in. For a low monthly membership fee – with a Drug Club membership – our members gain access to significant discounts on thousands of prescription medications. There are no deductibles, no claim forms, and no hidden fees. Simply present your TheDrugClub membership card at participating pharmacies, and you could see substantial savings, often reducing the cost of necessary medications by a large percentage. This means more predictable healthcare expenses and less financial stress for families navigating the challenges of NEHI.
Don't let the cost of prescriptions add to the burden of managing your child's health. Join
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.